Brady Collins
Meningococcal disease is a serious illness that can cause lasting disability or death, and it is highly contagious. Vaccines are available to prevent this disease, and they are especially recommended for children and teens, as they are in the highest risk age group. While meningococcal vaccines are generally safe, with only mild side effects, they do not provide indefinite protection against the disease. Protection from the vaccines lasts about five years, and people with an increased risk for serogroup A, C, W, or Y and B meningococcal disease need regular boosters.
| Characteristics | Values |
|---|---|
| Effectiveness | Protection lasts about five years, with effectiveness waning after 3 to 8 years. |
| Types of vaccines | MenACWY, MenB, MenABCWY, MenACWY-D, MenACWY-CRM |
| Side effects | Mild and usually go away within a few days. May include swelling, redness, pain, headache, muscle aches, fever, tiredness, and in rare cases, allergic reaction. |
| Recommended for | Children, teens, and adults at increased risk for meningococcal disease. |
| Protection against | Four types of bacteria that cause meningococcal disease, including meningitis and bloodstream infections. |
| Ingredients | Killed or inactivated bacteria |
| Boosters | Regular boosters are needed for people with prolonged increased risk. |
Explore related products
What You'll Learn
- Meningococcal vaccines are effective for up to five years
- The vaccines protect against four types of meningococcal bacteria
- Vaccines are recommended for children, teens, and adults at risk
- Side effects are usually mild and last a few days
- Vaccines are especially important for travellers to endemic areas
Meningococcal vaccines are effective for up to five years
Meningococcal disease is a serious illness that can cause bacterial meningitis and bloodstream infections. It is uncommon but can be deadly, and it is highly contagious. The disease can lead to lasting disability or death, and it is important to get vaccinated, especially for those living in close quarters, such as college dorms. Vaccines are part of the routine childhood immunization schedule and are recommended for preteens, teens, and adults who are at higher risk.
The MenACWY vaccine protects against four types of meningococcal bacteria: groups A, C, W, and Y. The MenB vaccine is also available and recommended for those at increased risk, including individuals with immune disorders or allergies. The timing and need for booster doses may vary depending on an individual's health condition, age, and vaccination history. It is important to consult a healthcare provider to determine the appropriate vaccination schedule and type of vaccine.
Meningococcal conjugate vaccines (Menactra and Menveo) are recommended for preteens and teens, while serogroup B meningococcal vaccines (Bexsero and Trumenba) are suggested for those aged 16-23, especially before entering college. Vaccines are available for free or at low cost through various programs, such as federally funded health centers and insurance plans. The availability of specific vaccines may vary, so it is recommended to consult a healthcare provider or local health department for the most up-to-date information.
Blue Cross Blue Shield: Understanding Your Vaccine Coverage
You may want to see also
Explore related products
The vaccines protect against four types of meningococcal bacteria
Meningococcal disease is uncommon but can cause serious illness and even death. It is the leading cause of bacterial meningitis in young children under 5 in the US, and can also cause sepsis, pneumonia, and long-term problems like permanent hearing loss or brain damage. The disease is highly contagious, and travellers are known to bring it back from endemic areas.
Meningococcal vaccines help protect against meningococcal disease. The vaccines contain killed, or inactivated, bacteria, which means that the vaccines themselves cannot cause the disease. After vaccination, the body's immune system creates antibodies that can recognise and fight the disease. These antibodies last a long time in the body. Vaccination of teens added an 80% drop in infections with serogroup C, W, and Y strains.
The meningococcal vaccine protects against four types of meningococcal bacteria that cause meningococcal disease. These bacteria can cause meningitis, an infection of the lining around the brain or spinal cord, as well as a blood infection (meningococcal bacteremia), pneumonia, and other problems. Between 10% and 15% of people who are infected with the disease die from it, even if they were treated with antibiotics. As many as 20% of those who survive may suffer from lasting problems such as hearing loss, brain damage, seizures, or loss of limbs.
There are two types of meningococcal vaccines available in the US: MenACWY and MenB. The MenACWY vaccine is further divided into MenACWY-D (Menactra) and MenACWY-CRM (Menveo). The MenB vaccine includes Trumenba and Bexsero. People with prolonged increased risk for serogroup A, C, W, or Y and B meningococcal disease need regular boosters.
The CDC recommends meningococcal vaccination for children and adults at increased risk for meningococcal disease. It is part of the routine childhood immunization schedule. Vaccines should be given during the highest risk age periods, which are during the preteen and teen years, and for those aged 16-23, especially before college entry.
Illinois Vaccines: Who's Eligible Now?
You may want to see also
Explore related products
Vaccines are recommended for children, teens, and adults at risk
Meningococcal disease is a serious but uncommon illness that causes bacterial meningitis and bloodstream infections. It can be deadly if untreated, but vaccines can help prevent it. The vaccines contain killed or inactivated bacteria, which means they cannot cause the disease. After vaccination, the body's immune system produces antibodies that can recognise and fight off the disease. These antibodies last a long time in the body.
Meningococcal vaccines are part of the routine childhood immunisation schedule in the US. They are recommended for preteens and teens, as well as other children and adults at increased risk of contracting the disease. This includes those who live in or travel to countries where the disease is common, those present during a meningococcal outbreak, and those with certain immune disorders.
The timing of vaccination depends on an individual's age, health, and risk of infection. Most people receive their vaccines during regular check-ups in their preteen and teen years. The MenACWY and MenB vaccines are typically given separately, but they can be administered together. The MenACWY vaccine is often given to younger children (as early as 8 weeks of age) if they have a higher risk of contracting meningococcal disease. The MenB vaccine is recommended for children over 10 who are at higher risk. Teens and young adults between the ages of 16 and 23 can also receive the MenB vaccine, preferably between 16 and 18 when their risk of infection is highest.
For adults, the recommended places to receive vaccines include healthcare providers' offices or pharmacies. Federally funded health centres and community health departments can also provide information and services for those without a regular source of healthcare.
Meningococcal vaccines are generally safe, with most people experiencing mild side effects such as redness, swelling, and pain at the injection site. These side effects typically last a few days and go away on their own. However, as with any vaccine, there is a small risk of more serious reactions, including allergic reactions, which require immediate medical attention.
College Students: State Residents for Vaccine Purposes?
You may want to see also
Side effects are usually mild and last a few days
Meningococcal disease is uncommon but can cause serious illness and death in people of all ages. It is the leading cause of bacterial meningitis in young children under 5 in the US. Meningococcal vaccines help protect against meningococcal disease. The meningococcal vaccine protects you from four types of bacteria that cause meningococcal disease. This illness can cause meningitis, an infection of the lining around the brain or spinal cord. It can also cause a blood infection (meningococcal bacteremia), pneumonia, and other problems.
The side effects of the meningococcal vaccine are usually mild and last a few days. These may include swelling, redness, and pain at the site of the shot. Sometimes, people may experience a headache, muscle aches, fever, or tiredness. These side effects typically resolve on their own within a few days. However, it is important to note that there is a small risk of fainting, and a very small chance of an allergic reaction.
The duration of protection offered by the meningococcal vaccine varies. Some sources suggest that protection lasts about five years, while others indicate that effectiveness wanes three to eight years after vaccination. To maintain protection, booster doses are often recommended, especially for individuals with an increased risk of contracting the disease.
It is always advisable to consult with a healthcare professional or vaccine provider to discuss any concerns or questions regarding the meningococcal vaccine, including potential side effects and the recommended immunization schedule.
Smallpox Vaccines: Availability and Access in the USA
You may want to see also
Vaccines are especially important for travellers to endemic areas
There are no sources that indicate the existence of a meningococcal vaccine that lasts forever. However, the antibodies produced by the meningococcal vaccine can last a long time in the body.
Meningococcal disease occurs sporadically worldwide and in focal epidemics, with the traditional endemic areas being the savannah regions of sub-Saharan Africa, stretching from Gambia and Senegal in the west to Ethiopia and Eritrea in the east. The disease is also associated with the Hajj pilgrimage to Mecca, Saudi Arabia. Therefore, it is crucial for travellers to these regions to be vaccinated.
Additionally, measles, mumps, and rubella are endemic in many countries, and travellers should ensure they have received two doses of the MMR vaccine. This is especially important for those born in or after 1970, who do not have documented evidence of receiving the MMR vaccine or natural immunity.
Hepatitis A is one of the most common vaccine-preventable diseases in travellers, and protection against it is recommended for all travellers to endemic countries, particularly those visiting rural areas or places with inadequate sanitary facilities.
For those travelling to regions where Japanese encephalitis is prevalent, such as rural agricultural areas in Asia, vaccination is advised, especially for those at high risk of infection. Similarly, rabies immunization is recommended for travellers to endemic areas with poor or unknown access to adequate post-exposure management.
In summary, it is essential for travellers to be aware of the endemic diseases in their intended destinations and to seek appropriate vaccinations to reduce the risk of infection and prevent the potential spread of diseases to new regions.
Live Vaccines: Faster Protection Than Dead Vaccines?
You may want to see also
Frequently asked questions
Protection from the meningococcal vaccine lasts about five years. The CDC recommends two doses during preteen and teen years, with a booster dose a few years later.
The meningococcal vaccine protects against meningococcal disease, which can cause meningitis and bloodstream infections. It also helps prevent pneumonia, sepsis, and long-term issues like permanent hearing loss or brain damage.
Most people do not experience any side effects from the meningococcal vaccine. However, mild side effects such as swelling, redness, and pain at the injection site may occur and typically go away within a few days.
